Tokyo, Oct. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063298) titled 'Study to evaluation the skin quality improvement effects of 12 weeks continuous use of Bis-Glutathione Trisulfide formulation' on Oct. 20.
Study Type:
Interventional
Study Design:
Basic Design - Factorial
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Mitsubishi Corporation Life Sciences Limited
Condition:
Condition - Healthy Adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We will evaluate the effects on skin condition (moisturization, firmness and elasticity, skin brightness and ...